Kyowa Hakko Kirin Co Ltd announced that AstraZeneca obtained the positive top-line results that benralizumab, a potential new medicine and...
Pfizer Inc and Anacor Pharmaceuticals Inc announced that they have entered into a definitive merger agreement under which Pfizer will...
Allergan plc announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator, OCUN-009 and OCUN-010, each met their primary...
Eisai Co Ltd announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. FDA for an additional...
Chugai Pharmaceutical announced that "Actemra® Subcutaneous Injection" , the humanized antihuman IL-6 receptor monoclonal antibody, successfully met the primary endpoint...
Otsuka Holdings Co Ltd announced the signing of a development and commercialization agreement with ReCor Medical Inc. (“ReCor”), together with...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
Swedish Orphan Biovitrum AB and Biogen announced that the European Commission (EC) has approved Alprolix® (rFIXFc), their extended half-life therapy,...
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety...
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
